1

LDA/Columbia Lyme Conference May 3-4 2014 CME & CE

LDA and Columbia University 15th Lyme & Tick-Borne Diseases Scientific Conference offering CME (physician) & CE* (social worker, psychologist) credits to be held in Providence, RI.  Conference is now over.

15th Annual Lyme & Tick-Borne Diseases: 

Medical, Neuropsychiatric & Public Health Implications 

Marriott

 Jointly sponsored by 

  Columbia University

College of Physicians & Surgeons

and
  Lyme Disease Association, Inc.
 

 Saturday, May 3 & Sunday May 4, 2014

  Marriott Downtown, Providence, RI 

 


Registration Not Available – Conference Complete

This conference is designed for medical and health professionals. The conference is also open for the general public to register. Adults only. 

Online Regular Registration  (For those who do not require Continuing Medical Education (CME) credits) 

Online CME Registration (Continuing Medical Education registration for physicians)

Printable By Mail Registration Form – (by mail is no longer available please use online registration)

At the door registration is limited by space (check website day of conference to see if available, if so you must bring a check to door)

For CE registration  (Continuing education)  Register using regular registration and be prepared to pay an additional $30 in cash or check at the door (check payable to Lyme Disease Association, Inc). You must register for the conference through regular registration online or by mail first to be guaranteed entrance at the door, when you will then pay the additional $30 fee. Check below to see if you need to go through a verification process.

Social Workers CE:  12.5 CE credits for RI social workers authorized from NASW RI Chapter, Authorization # RI-5570. Social workers in other states, contact your professional organization for reciprocity.     Psychologists CE: All psychologists from all states contact your professional organization for reciprocity.  LDA makes no guarantees for out of state social workers or any psychologist that your professional organization will accept these CE credits. You yourself must verify reciprocity and acceptance with your professional organization.  

Questions on registration contact: treasurer@lymediseaseassociation.org


General Registration Information

►  Fees:
Regular – Early $199 (by 04/05/14); $220 (after 04/05/14); $230 (if space available, at door)
• CME – Early $310 (by 04/05/14); $340 (after 04/05/14); $370 (if space available, at door)

• CE- Regular registration price (above) plus $30 additional in cash/check at the door

Note: Early registration discount expired on 04/05/14.  

►  No phone or fax registrations accepted 

►  The availability of last minute “at the door” registrations is determined by the room capacity and number of registrants on day of conference.  Please note, the rate to register “at the door” will be higher than the pre-registration fee.  There is a CASH or CHECK ONLY policy when registering “at the door”

►  CANCELLATION: Written notice of cancellation must be received by LDA by 04/10/14 for refund, NO exceptions.  Email cancellation notice to treasurer@LymeDiseaseAssociation.org or fax 732-938-7215

►  AVAILABILITY: Registration subject to space availability at the time of receipt by LDA of completed registration. NO registrations accepted without payment.    


Accreditation, Disclosure, Audience, Need & Objectives 

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the College of Physicians and Surgeons of Columbia University and the Lyme Disease Association. The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The College of Physicians and Surgeons designates this live activity for a maximum of 13.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:
The College of Physicians and Surgeons must ensure balance, independence, objectivity, and scientific rigor in its educational activities. All faculty participating in this activity are required to disclose to the audience any significant financial interest and/or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in his/her presentation and/or the commercial contributor(s) of this activity. When unlabeled uses are discussed, these will also be indicated. 

Target Audience:
The target population is physicians from all specialties, nurses, psychologists, scientists, public health workers. It is also open to the public, and Lyme disease educators generally attend. The geographic area being reached is nationwide. No special background is required for effective participation, although those whose practices contain a high proportion of Lyme disease patients and those whose research concentrates on Borrelia burgdorferi will receive the most benefit.

Educational Need the Activity Addresses:
As a result of participation in this conference, attendees will be better able to diagnose and understand the pathogenesis of Lyme disease and mechanisms of persistence. Clinicians will be able to assess the impact of tick-borne diseases on pregnant women. Healthcare providers will be better equipped to explain to patients the new developments in the area of how the immune system may be causing persistent symptoms and discuss the role of nutrition in patient outcomes.

Course Objectives:

1  Ability to identify multiple manifestations of Lyme disease

2  Awareness that ticks may transmit viruses (flavivirus, Lonestar virus)

3  Awareness that animal studies demonstrate Borrelia persistence

4  Awareness that genetic predispositions may lead to chronic Lyme arthritis

5. Understanding of new vaccines being developed

 The LDA thanks IGeneX, Inc. for an educational grant in support of this conference.




2015 LDA Conference Online CME Registration

 

16th Annual Scientific Conference
Lyme & Other Tick-Borne Diseases: Science Bridging the Gap

 
2-Day Conference Jointly Provided by:

Columbia University College of Physicians & Surgeons
and
Lyme Disease Association, Inc.

 

Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the College of Physicians and Surgeons of Columbia University and the Lyme Disease Association. The College of Physicians and Surgeons of Columbia University is accredited by the ACCME to provide continuing medical education for physicians.  

AMA Credit Designation Statement  The College of Physicians and Surgeons designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.


CME Registration Fees: Individuals who require Continuing Medical Education credits

  • $350 (through 10/10/15), Early Registration*
  • $375 (beginning 10/11/15)*
  • $400 (if space available, at door – payable by check or cash only)*

Saturday, November 14, 2015   8:00 a.m.- 5:15 p.m.  Reception 5:30 p.m.-7:30 p.m.

Sunday, November 15, 2015     8:00 a.m.- 2:00 p.m.

Registration Information

  • One form per registrant 
  • Fee includes Sat. breakfast, lunch, breaks, reception, scientific lectures, exhibits; Sun. break, scientific lectures, exhibits; program
  • Online Registrations by credit card only    (No Phone or Fax Registrations accepted)
  • Cancellation: Written cancellation notice must be received by LDA by 10/3/15 for refund.*  NO exceptions.  Email cancellation notice to treasurer@LymeDiseaseAssociation.org or fax 732-938-7215
  • No video or audiotaping of any part of the conference permitted

*Deadlines are based on Eastern Time

{rsform 43}

IMPORTANT

Registration is a 2 step process: 

1) After you click the submit button you will have completed the LDA portion of the registration.  An email confirm will be sent by LDA, check your SPAM box if you do not receive it. 

2) Next you will be sent to the PayPal page to input your credit card information and finish registration.  An email confirm will also be sent by PayPal which you need to bring to the conference.  If you have registered and do not receive a PayPal confirm within 24 hours of your online payment, please email treasurer@LymeDiseaseAssociation.org 

 

 

 

 

 

 

 

 

 

 




2013 Annual Scientific Conference: Science, Research & Myth

1st Upper Midwest Lyme Conference

The Lyme Disease Association, Inc. held its 14th annual scientific conference, Lyme & Other Tick-Borne Diseases: Science, Research & Myth at the University of Minnesota, St. Paul, MN, on Saturday June 1 and Sunday June 2, 2013. 11.0 Prescribed CME Credits were offered to physician attendees. Seventeen faculty consisting of clinicians and researchers, one from Switzerland, Dr. Judith Miklossy, discussing Lyme and its relationship to Alzheimer’s, another Dr. Charlie Johnson, a physicist from UPenn, presenting a novel test for Lyme using nano technology, educated an audience consisting of many physicians, researchers, health care providers, and the public. CBS News came and interviewed LDA president Pat Smith, and took clips from clinician Dr. Sam Shor as he presented. Portions of the conference were also taped and will be broadcast on public television in the Minneapolis area and may be featured on the LDA website.. Further details will follow.

Click here for Agenda

 

Click here for Faculty Biographies
Click here for Conference Flyer

 


Click here for video of 14th Annual Scientific Conference (Part 1 of 6)
Click here for video of 14th Annual Scientific Conference (Part 2 of 6)
Click here for video of 14th Annual Scientific Conference (Part 3 of 6)




2012 LDA Conference Summary

Conference Reveals Lyme Can Persist After Short-Term Therapy

Animal models confirm survival of Lyme spirochete in spite of treatment

By Jessica Thomson *

JessThomsonAn eclectic group of scientists, researchers, physicians, veterinarians and molecular biologists assembled in Philadelphia to present scientific research and clinical papers for Lyme and other tick-borne diseases last September.

The purpose of the continuing medical education (CME) scientific conference is to educate the physicians and researcher attendees about Lyme and other tick-borne diseases. The knowledge gleaned is used to improve their medical practices if they are clinicians and is used to foster collaborations with others if they are researchers The public and advocate attendees are able to disseminate scientifically and clinically established information to patients and may select new research projects to fund based on what the conference faculty has presented.

Brian Fallon, MD, MPH
Fallon2Dr. Fallon, conference director and co-chair, said that the conference unites ivory tower researchers “with the people.” Dr Fallon serves as Director of Columbia University Lyme & Tick-Borne Diseases Research Center. “The conference also brings together the researchers with the clinicians, so the researchers can hear first-hand what the clinicians are struggling with. And, it fosters collaboration among researchers,” Fallon added.

“If I were a patient, I’d be most excited about knowing that researchers are taking this disease seriously and coming together to prove Borrelia’s persistence despite antibiotics. Until recently, that was considered to be an impossibility.”

The publication of research helps the Lyme community contest the theory that it was extraordinarily unlikely for persistent Lyme to occur post treatment. “Now we have these major studies published where nobody can dispute the persistence of the organism,” Fallon said.

Stephen W. Barthold, DVM, PhD
BartholdDr. Barthold, Director, Center for Comparative Medicine at UC Davis, has been involved in Lyme disease research since its discovery in Connecticut over 35 years ago. His training as a pathologist and his lengthy career as a veterinarian are an important foundation for examining Lyme disease. He explained that being a veterinarian allows him to examine the life stages and variation of host responses of Borrelia in animals, then interpret and apply the results to humans. “Animal model studies are critical to get a handle on what’s going on with Lyme disease. Unless you understand the life stages of Borrelia and the variation of host response, you’ll never get a true understanding,” he said.

Dr. Barthold, keynote speaker and conference co-chair, said he helped choose presenters for the conference from the Lyme scientific community he has worked with over the years, calling them “a wonderful group with wonderful diversity.” Speaking of his fascination with the complexity of the Lyme disease organism, he said, “It truly needs multiple disciplines looking at it from multiple perspectives.”

Lyme disease draws a wide range of medical and research specialists, because it is as much an ecological disease as an individual disease, he explained. He spoke about the global migration of other diseases spreading to different climatic territories due to global warming. For example, a cow and sheep disease called Blue Tongue is also affected by environmental changes.

Dr. Barthold called Lyme disease “tough to crack.” With multiple studies conducted among multiple labs with multiple antibiotic treatments, all evidence points to the Lyme bacteria as very persistent, he said.  Dr. Bathold explained that most diseases take a long time to gain momentum for positive change, and he understood the sense of frustration among members of the Lyme community who have been asking for amended diagnostic and treatment protocols for years. “Medical science is like a fault zone, and it sticks (in one place) for awhile,” he said.

Drawing on AIDS as an example of another disease that took time to be properly recognized, Dr. Barthold spoke about the disconnect between the patient experience and science generalizing without enough evidence. He believes that the restrictive IDSA Lyme guidelines can change when everyone learns to keep an “open mind” when approaching the disease.

He said that the division of the medical community is nothing new. Medical history is full of stories where the medical community becomes dogmatic and refuses to change its opinion even when evidence is showing the truth. “It’s only when there’s enough collective evidence and people behind it that the disease can move forward,” he said. “Lyme disease is at a crucial point where it’s starting to move forward,” he added.

According to Dr. Barthold, progress in Lyme disease is also slow due to the multiple verifications and repetitions required in scientific research. He feels that the current political environment is killing the advancement of science. Today’s science graduates are not interested in launching a career in Lyme research because there is an uphill battle getting grants, he said. Of the half dozen Lyme disease grants that are proposed each year, the chances of even one of them getting funded is very slim “because if a grant is in any way controversial, that’s enough to stop funding,” said Dr. Barthold. He thinks the only way to change matters is to pressure Congress to give some attention to the way the government is awarding grants.

Dr. Barthold urged the medical community to get out of the dark ages in their thinking about antibiotics. He explained that while antibiotics can cure infection for streptococcus, it is different for Lyme disease because Borrelia is an infection that can evade a perfectly good host immune response as part of its normal biology. That is the problem. The surviving forms of Borrelia are not able to be cultivated, however, so they are different in some way, he said.

Janis Weis, PhD
WeisJanis Weis, who has been researching genetics in mice, sometimes feels distant from patients, but “being around patients and advocates at the conference was invigorating. It’s a reminder of why we’re doing all the work we do and makes me feel like I’m on the right track.” Weis spoke of the years of work behind each of the presentations at the conference. She was happy that finally there seems to be progress in understanding why symptoms are persistent, a concept finally being taken seriously because of the studies using animal models.

Weis’ mouse studies hold significance for patients because they serve as a model for chronic patients who have been treated with antibiotics but whose inflammation persists. Like humans, mice that get swollen joints and have similar pathology serve as a guide to human studies. Her studies have identified that mice once infected with Lyme disease lack an anti-inflammatory protein so they have an over-active immune response. While this over-active immune response clears the bacteria better from tissues, it also results in severe arthritis that persists even after the bacteria can no longer be detected.

Weis is most excited about the Transpogenesis work being done by Steven J. Norris, PhD, another conference speaker. She stated that it “could lead to new discoveries of bacterial genes that could be important for persistence. He’s looking at antigenic variation and how the bacteria evade the immune response.” Weis also learned from the work of LDA conference speaker Nicole Baumgarth, DVM, PhD, with B-cell subversion during Borrelia infection. Weis added that it is a novel concept to find that the IgG becomes more effective if you don’t have

C. Ben Beard, PhD
BeardC. Ben Beard, PhD, Chief, Bacterial Diseases Branch of the Vector-Borne Diseases, Centers for Disease Control and Prevention (CDC), believes the conference is “a great place for scientific minds to come together for honest conversations that can lead to increased trust”

Dr. Beard said he disagreed that Lyme disease is hard to catch and easy to cure. The CDC numbers in his presentation revealed that it’s the most common vector-borne disease in the country, the second most common reportable disease in the Northeast, the third most common in the entire East Coast and the sixth most common in the whole country, “which all prove that Lyme disease is easy to get,” he said.

Dr. Beard admits that even those figures are not accurate because a large number of patients are not being counted properly. He says that he wants the CDC to wake up and acknowledge that Lyme is an important disease. “Our view is there’s lots of tick-borne disease, but we’re not sure it’s [all] Lyme disease,” Dr. Beard said.

Dr. Beard spoke about the double-edged sword that accompanies accurate reporting. “When numbers go up we’re thinking we’ll get more money (for surveillance) but we’re also thinking it’s bad because we’re losing the battle (more people are becoming infected),” he said.

People complain about low surveillance numbers, but dr. Beard’s explanation is that their entire budget could be spent just on surveillance and it still might not be accurate or give them the information they need about how the disease is spreading. The CDC is focusing on 16 states where 97% of all Lyme cases are reported, so they can do a better job of counting, he said. The CDC cannot go into everyone’s backyard to count ticks, Dr. Beard explained. “We just do not have the resources,” he added.

As far as the CDC’s stance on the current number of Lyme cases in the US, he explained, underreporting ranges from three to 12 fold but in reality, the CDC has no idea of how much Lyme disease there is on a national level, which is an astonishing admission.

“[The CDC] is a pro-patient organization – what’s good for public health is good for the patient,” Dr. Beard said. He even calls himself a “Lyme activist.”

Monica Embers, PhD
EmbersDr. Monica Embers presented her findings of post-treatment persistence and sero-diagnosis of Lyme disease in monkeys. Her team has been investigating antibiotic efficacy in controlled animal studies because humans come with varied duration before diagnosis.

“There are lots of different genospecies in nature,” Dr Embers explained, “so we’re doing what we can to try to understand, using the right kind of model systems where infection is controlled, treatment is controlled, and we can really look inside.” Dr. Embers said she was pleased to see that “there’s real momentum, things are really moving along” in research studies for Lyme disease.


NOTE: Ms.Thomson wrote the article for the Lyme Disease Association based on presentations from Faculty at the 2012 conference where she was in attendance and also on post presentation interviews with speakers she taped for the LDA.




2013 Conference Faculty Biographies

Click on name to link to bio: 

John Aucott, MD Brian A. Fallon, MD, MPH Richard Rhee, MD, FAAN
Nicole Baumgarth, DVM, PhD Leila Zackrison, MD Sam Shor, MD, FACP
Edward B. Beitschwerdt, DVM A.T. Charlie Johnson, PhD RW (Bill) Stich, MD, PhD
George Chaconas, PhD Kenneth B. Liegner, MD Ellen Stromdahl, MS, BCE
Madeleline W. Cunningham, PhD Elizabeth Maloney, MD Ernest Visconti, MD 
Sam T. Donta, MD Judith Miklossy, MD, PhD, DSc

 


 

AucottJohn Aucott, MD
Assistant Professor in Medicine, Johns Hopkins Hospital
Johns Hopkins University, Baltimore, MD

Private Practice: Board Certified, Internal Medicine
10755 Falls Road, Suite 200
Lutherville, MD, 21093

Erythema Migrans (EM) in Lyme Diagnosis

Dr. Aucott is a graduate of the University of California at Berkeley where he was elected to the membership of Phi Beta Kappa. He attended the Johns Hopkins University School of Medicine, and is a Diplomate of the American Board of Internal Medicine with sub-specialty training in Infectious Disease and Geographic Medicine at University Hospitals of Cleveland. He served as the Section Head for General Internal Medicine and the Residency Program Director at the Cleveland Veterans Affairs Medical Center while on the faculty at Case Western Reserve University School of Medicine from 1989-1996. He was promoted to Associate Professor of Medicine in 1995.

In 1996, Dr. Aucott returned to Baltimore to join the clinical Faculty of Medicine at Johns Hopkins School of Medicine where his focus has been on clinical translation research in Lyme disease. He is currently the Principal Investigator for the prospective cohort study, SLICE, examining the impact of acute Lyme disease on long-term health outcomes and immune function.

Dr. Aucott is the founder of the Lyme Disease Research Foundation, a public non-profit organization founded to promote research and education in Lyme disease. He has lectured through programs sponsored by Johns Hopkins Divisions of Medicine and Infectious Diseases, the American College of Physicians, and other major medical programs in the United States. He has published numerous articles in the field of infectious diseases and Lyme disease.  

Back to Top


BaumgartNicole Baumgarth, DVM, PhD
Center for Comparative Medicine
University of California, Davis
County Rd 98 & Hutchison Dr.
Davis, CA 95616

B cell subversion during Borrelia infection – a persistence strategy

Nicole Baumgarth is a DVM, PhD and Professor of Immunology at the Center for Comparative Medicine, University of California, Davis. She is also the Chair of the Graduate Group in Immunology there. Dr. Baumgarth’s research encompasses studies on the regulation of immune responses to infections and B cell biology. Much of her recent work has focused on the regulation of B cell responses and B cell subset responses using mouse models to two very different pathogens and immune responses: Acute influenza virus infection, an infection that fully resolves and induces highly protective and long-lived B cell-mediated immunity, and B cell responses to Borrelia burgdorferi, a bacterial spirochete and the causative agent of Lyme disease. Infections with B. burgdorferi induce strong B cell responses, however, those responses to not result in clearance of the infection. By contrasting a successful with a not-successful B cell response her group hopes to uncover important immune regulatory mechanisms that shape the quality of the B cell response.

Back to Top


BreitschwerdtEdward B. Breitschwerdt, DVM
Professor of Medicine and Infectious Diseases
North Carolina State University College of Veterinary Medicine
Adjunct Professor of Medicine, Duke University Medical Center
Diplomate, American College of Veterinary Internal Medicine (ACVIM)
Raleigh, NC

Bartonelliosis:  A One Health Approach to a Persistent Blood-Borne Infection 

Dr. Edward B. Breitschwerdt is a professor of medicine and infectious diseases at North Carolina State University College of Veterinary Medicine. He is also an adjunct professor of medicine at Duke University Medical Center, and a Diplomate, American College of Veterinary Internal Medicine (ACVIM).  Dr. Breitschwerdt directs the Intracellular Pathogens Research Laboratory in the Center for Comparative Medicine and Translational Research at North Carolina State University. He also co-directs the Vector Borne Diseases Diagnostic Laboratory and is the director of the NCSU-CVM Biosafety Level 3 Laboratory.

A graduate of the University of Georgia, Breitschwerdt completed an internship and residency in Internal Medicine at the University of Missouri between 1974 and 1977. He has served as president of the Specialty of Internal Medicine and as chairman of the ACVIM Board of Regents. He is a former associate editor for the Journal of Veterinary Internal Medicine and was a founding member of the ACVIM Foundation.

Breitschwerdt’s clinical interests include infectious diseases, immunology, and nephrology. For over 20 years, his research has emphasized vector-transmitted, intracellular pathogens. Most recently, he has contributed to cutting-edge research in the areas of animal and human bartonellosis. In addition to authoring numerous book chapters and proceedings, Dr. Breitschwerdt’s research group has published more that 300 manuscripts in peer-reviewed scientific journals. In 2012, he received the North Carolina State University Alumni Association Outstanding Research Award and in 2013 he received the Holladay Medal, the highest award bestowed on a faculty member at North Carolina State University

Back to Top


ChaconasGeorge Chaconas, PhD
Canada Research Chair in the Molecular Biology of Lyme Borreliosis
Department of Biochemistry & Molecular Biology
The University of Calgary
Calgary, AB
Canada

Live Imaging Studies of Dissemination of the Lyme Spirochete in Mice

George Chaconas obtained his Ph.D. in the Division of Medical Biochemistry at the University of Calgary in Alberta, Canada and did postdoctoral work Cold Spring Harbor Laboratory in New York. He subsequently took a faculty position in the Department of Biochemistry at the University of Western Ontario. His laboratory focused on the molecular mechanism of DNA transposition or “how jumping genes jump”. In 1999-2000, with the help of a Guggenheim Fellowship, George’s research interests took a turn through a sabbatical at the NIH Rocky Mountain Labs in Montana where he began working on the Lyme disease pathogen Borrelia burgdorferi. In 2002 he took a position in the Department of Biochemistry & Molecular Biology and the Department of Microbiology & Infectious Diseases at the University of Calgary in Alberta, Canada where he is currently Professor, Scientist of the Alberta Heritage Foundation for Medical Research and holds the Canada Research Chair in the Molecular Biology of Lyme Borreliosis.

Back to Top


CunninghamMadeleine W. Cunningham, PhD
George Lynn Cross Research Professor
Presbyterian Health Foundation Presidential Professor
Microbiology and Immunology
Director, Immunology Training Program
University of Oklahoma Health Sciences Center
Biomedical Research Center
Oklahoma City, OK

Anti-Neuronal Antibiodies in Lyme Disease

Dr Cunningham received her PhD in1973 at University of Tennessee-Memphis in Microbiology and Immunology. She studied for 3 years as a postdoctoral fellow in Protein Studies at the Oklahoma Medical Research Foundation in Oklahoma City. Following her postdoctoral fellowship, she accepted a position at the University of Oklahoma Health Sciences Center & has maintained an active laboratory since 1980.
Research in Dr. Cunningham’s laboratory investigates molecular mimicry, autoimmunity and infection in inflammatory heart diseases and in behavioral and movement disorders.

Her laboratory studies autoimmunity, infection and behavior which is manifest in diseases such as Sydenham’s chorea and in pediatric autoimmune neuropsychiatric disorder following group A streptococcal infection (PANDAS). Using human monoclonal antibodies, the work has identified antibody mediated neuronal cell signaling as a potential basis for movement or neuropsychiatric disorders and potentially other brain related disorders, including obsessive compulsive disorder, Tourette’s Syndrome and Tics. These diseases including PANDAS are under investigation to determine the relationship of autoantibodies which bind to brain antigens or signal in the brain to development of symptoms. Investigation of Lyme disease for autoantibodies against the brain has been funded by the Lyme Disease Association and the study is underway in her laboratory. She was funded by the National Institute of Mental Health Bench to Bedside Grant to investigate autoantibodies in PANDAS in the recent IVIG trial.

In addition, her laboratory investigates the pathogenesis of rheumatic carditis, a sequela of group A streptococcal pharyngitis, and of myocarditis, a complication that can follow coxsackieviral infections. Rheumatic carditis affects the heart valves, while myocarditis results in the destruction of the myocardium. Studies in myocarditis currently are supported by the National Heart Lung and Blood Institute and are focused on a 5 year longitudinal study of T cell subsets and monocyte responses in patients with myocarditis who develop cardiomyopathy. Translational research using human monoclonal antibodies and T cell clones from disease have provided clues about pathogenic mechanisms in disease. Other work funded by the National Heart Lung and Blood Institute includes studies of the pathogenesis of hypoplastic left heart syndrome in infants.

Dr. Cunningham has served many years on review panels at the National Institutes of Health and served on the National Research Committee at the American Heart Association. She was a representative of the United States for the US-Indo Vaccine Action Program. She was elected an AAAS fellow and ASM fellow. She received a National Heart Lung and Blood Institute Research Career Development Award and Merit Award. She has been supported by the NIH for the past 25 years. She is the Director of the NIAID supported Immunology Training Program at the University of Oklahoma Health Sciences Center. She lectured on the effects of autoantibodies on the brain in the Presidential Symposium at the American Association of Immunologists in 2010. Dr Cunningham is the author of over 100 publications.

Back to Top


DontabSam T. Donta, MD
Consulting Physician in Infectious Diseases Fairmouth Hospital
Falmouth, MA

Issues in the Treatment of Lyme Disease

Dr Donta grew up in Western Pennsylvania, received his BS from Allegheny College, his MD from Albert Einstein College of Medicine, did an internship/residency in Internal Medicine at U. of Pittsburgh Hospitals, served in Air Force at Otis AFB, MA, did post-doctoral training in Biochemistry at Brandeis, and Fellowship in Infectious Diseases at Boston Univ.

He went to U. of Iowa where he became Professor of Medicine and Chief of Infectious Diseases, then was at U. of Connecticut for 11yrs as Chief of ID, Chief of Medicine at VA, then moved to Boston University/Boston VA for 10yrs before his retirement.

His basic interests have been in microbial toxins, but he has also been involved in a number of clinical trials. For the last 25yrs, he has been interested in Lyme disease, and continues to have an active clinical practice in Falmouth, studying and treating patients with chronic Lyme disease and other multi-symptom disorders such as Chronic Fatigue Syndrome and Fibromyalgia.

He is the author of 100+ publications on toxins, Lyme Disease, Gulf War Veterans’ Illnesses, and hopes to continue research in these areas.

Back to Top


FallonBrian A. Fallon, MD, MPH (Course Co-Director)
Professor of Psychiatry
Director, Lyme and Tick-Borne Diseases Research Center,
Columbia University Medical Center
Director, Center for the Study of Neuroinflammatory Disorders & Biobehavioral Medicine, New York State Psychiatric Institute
New York, NY

Lyme Disease Or Hypochondriasis

Brian A. Fallon, MD, MPH. Dr. Fallon is director of the Lyme & Tick-borne Diseases Research Center at Columbia University Medical Center where he leads a team focused on biomarkers, diagnostics and treatment of chronic Lyme symptoms. His team’s recent work has included the testing of novel diagnostic assays in a large community study, as well as collaborating on new test development using the Columbia Lyme Center biorepository. His team’s work on Lyme encephalopathy led to the discovery of hundreds of unique proteins present in the CSF of Lyme patients but not in the CSF of patients with chronic fatigue syndrome or healthy controls. His team’s current focus is on clarifying the immunologic profile and neural circuitry of patients with persistent symptoms. His team is also investigating the CNS metabolic effects of intravenous ceftriaxone using MR Spectroscopy to probe glutamatergic transmission. Dr. Dwork in his Center is examining the neuropathologic findings in post-mortem studies of patients with chronic Lyme symptoms. Dr. Moeller in his Center is examining the interaction between peripheral immunologic markers, central immune markers, and brain neurocircuitry among patients with chronic symptoms with the goal of identifying of biomarkers to help guide treatment recommendations. Dr. Fallon serves on the editorial and review board of three journals, has lectured and published widely, and most recently has led an international team for the American Psychiatric Association’s revision of DSM-5 to clarify the prevalence of illness anxiety in the general population.

Back to Top 

 


 

JohnsonA.T. Charlie Johnson, BS, MS, PhD
Professor of Physics and Astronomy
Associate Chair for Graduate Affairs

Secondary Appoints in: Materials Science & Engineering and Electrical & Systems Engineering
University of Pennsylvania
Philadelphia, PA 

Detecting Lyme disease using antibody-functionalized single-walled carbon nanotube transistors

A. T. Charlie Johnson received a B.S. from Stanford University, and a M.S. and Ph.D. from Harvard University, all in Physics. He was a European Union ESPRIT Postdoctoral Fellow at the Delft University of Technology and a National Research Council Postdoctoral Research Fellow at the National Institute of Standards and Technology (Boulder, CO). He leads an independent research group at Penn, focused on nanostructure physics and nanoelectronics. Johnson worked extensively in the science of carbon nanotubes, making significant contributions to the understanding of thermal and electronic transport in this important nanomaterial. More recently he has been active in the area of vapor- and liquid-phase molecular sensing using functionalized nanotube field effect transistors, as well as graphene electronics and synthesis of wafer-scale graphene. Johnson was the recipient of an NSF Graduate Research Fellowship, a Packard Foundation Science and Engineering Fellowship, a Sloan Fellowship, and selection as a Fellow of the American Physical Society, among other honors. Along with the authorship of over 140 peer-reviewed articles, Johnson holds three awarded patents, with 18 other patents submitted. Johnson is a member of the Founding Editorial Board of AIP Advances. He is also a scientific founder of two companies based on technology from his laboratory, Graphene Frontiers and Adamant Technologies.

Back to Top


LiegnerKenneth B. Liegner, M.D.
Internal & Critical Care Medicine
Lyme Borreliosis & Related Disorders
Pawling, NY

Problems of Lyme Disease Testing

Dr. Kenneth Liegner is a Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York. He has been actively involved in diagnosis and treatment of Lyme disease and related disorders since 1988. He has published articles on Lyme disease in peer-reviewed scientific journals and has presented poster abstracts and talks at national and international conferences on Lyme disease and other tick-borne diseases. He has cared for many persons seriously ill with chronic and neurologic Lyme disease. His work has focused on the serious morbidity and (occasional) mortality that can eventuate from this aspect of the illness. He has emphasized the urgent need for widespread clinical availability of improved methods of diagnostic testing and for development of improved methods of treatment for Lyme disease in all its stages. He holds the first United States patent issued proposing application of acaricide to deer for area-wide control of deer-tick populations as a means of reducing the incidence of Lyme disease.  

Back to Top



MaloneyElizabeth Maloney, MD
Board certified in Family Medicine
President, Partnership for Health & Healing (accredited CME program provider)
Wyoming, MN

 The Ethics of Clinical Decision-Making When the Scientific Evidence is Unclear or Absent


Elizabeth L. Maloney, MD, is board-certified in family medicine and president of Partnership for Healing and Health, a company providing accredited CME programs on Lyme disease for physicians and other health professionals as well as Lyme disease education and training programs for private organizations and government agencies. She has published on Lyme disease in peer-reviewed journals and frequently lectures on Lyme disease at hospitals and medical conferences.

In addition to her clinical work, Dr. Maloney has held several physician leadership roles. She served as Chief of Staff at District Memorial Hospital and on the Board of Directors of Allina Medical Clinics, a multi-specialty healthcare system. Dr. Maloney is a member of the American Academy of Family Physicians, the Minnesota Academy of Family Physicians and the International Lyme and Associated Diseases Society.

Back to Top


MiklossybJudith Miklossy, MD, PhD, DSc
Board Certified in Neurology, Psychiatry, Psychotherapy and Neuropathology
Founder, Prevention Alzheimer Foundation
Director, International Alzheimer Research Center
Martigny-Combe, VS Switzerland

 

Late/Chronic Lyme Disease & its Relation to Alzheimer’s Disease

 Dr. Miklossy is the founder of the Prevention Alzheimer International Foundation and director of the International Alzheimer Research Center in Switzerland. She also practices memory and Lyme disease consultation in Vigimed Medical Center, Martigny, Switzerland.

She is board certified in neurology, psychiatry and psychotherapy (Faculty of Medicine, University of Debrecen, Hungary) as well as in neuropathology (Swiss Society of Neuropathology and Swiss Medical Federation). She has received the degrees of Private docent (Dr habil or DSc) and Maître d’Enseignement et de Recherche (MER) in the University Hospital Center of Lausanne (CHUV), University of Lausanne, Switzerland.

She was head of the Neurodegeneration research group for more than ten years in the University Institute of Pathology, Lausanne, Switzerland. She has done molecular biology research and participated in the introduction of Alzheimer’s research in the Center of Neurovirology, Department of Neuroscience, Temple University, Philadelphia, USA. She headed the neuropathology of the Kinsmen Laboratory of Neurological Research, in The University of British Columbia, Vancouver, Canada. She is on the board of directors or scientific advisory board of several international organizations or foundations.

For more than 25 years she is actively involved in research on Alzheimer’s disease and Lyme disease in the framework of international collaborations. Her presentations on international meetings and her publications were repeatedly considered for CME and press releases.

Back to Top


RheeRichard S. Rhee, M.D., F.A.A.N.
Clinical Professor of neurology
Robert Wood Johnson Medical School, UMDNJ
Founder & President, Jersey Shore Neurology Associates Group
Neptune, NJ

Lyme Disease: Neurologic Differential

Dr. Richard Rhee was born in South Korea and had extensive training in both internal medicine and neurology in New York City including Queens General Hospital (Internal Medicine), New York University – Bellevue Hospital and State University of New York Downstate Medical Center. He is certified in neurology, EEG, EMG and neurosonology. He did a fellowship in neurophysiology at Columbia Presbyterian Medical Center and remained as a part of the teaching faculty from 1971-1975 at the Neurological Institute of Columbia University. He has been in primary practice in neurology as the Founder and President of the Jersey Shore Neurology Associates Group in Neptune, NJ since 1975.

He has served as the President of multiple professional organizations including Monmouth County Medical Society of New Jersey, New Jersey Neurological Society, Korean-American Neurological Association (KANA) (Founding President), President of Korean-American Medical Association (KAMA) and since 1998 he has been serving as a member of the Scientific & Professional Advisory Board, Lyme Disease Association, Inc.

He has published numerous scientific articles in the field of Neurology including Lyme disease and lectured in the U.S.A. and abroad on the topics of neurological Lyme disease.

He has received multiple awards and honors including Prime Minister’s Award by the Republic of Korea, Ellis Island Award by National Ethnic Coalition of Organizations in the U.S.A., Faculty Teaching Award from Robert Wood Johnson Medical School, New Jersey State Board of Medical Examiners and Jersey Shore University Medical Center for his professional contributions. He currently serves as a Clinical Professor of neurology at Robert Wood Johnson Medical School – University of Medicine and Dentistry of New Jersey since 1981.

Back to Top 


ShorSamuel Shor, MD, FACP
Chair, Loudoun County Lyme Commission
Associate Clinical Professor
George Washington University Health Care Sciences
Internal Medicine & HBO Therapy of Northern Virginia
Reston, Virginia

 

Chronic Fatigue Syndrome & Lyme Disease – Is There A Connection?

Samuel Shor, MD, FACP; Associate Clinical Professor, George Washington University Health Care Sciences. Trained in Primary Care Internal Medicine, Dr. Shor has had an interest in chronic fatigue since starting practicing medicine in1985. His first peer reviewed publication was in 2003 on the Pathogenesis of Chronic Fatigue Syndrome a Multisystem Hypothesis. Soon thereafter he became interested in a possible connection between chronic fatigue and Lyme disease. Embracing that topic, he is presently chair of the Loudoun County Lyme commission and was a member of the 2010 Virginia Governor’s Lyme Task Force. He presented on the topic to a congressional hearing in 2008 and has twice been a participant on the nationally syndicated NPR Diane Rehm Show. Dr. Shor will now speak about his peer reviewed original research published in the Spring of 2011 in the on line Bulletin of the International Association of CFS/ME, A Retrospective Analysis of a Cohort of Internationally Case Defined Chronic Fatigue Syndrome Patients in a Lyme Endemic Area, the topic of his talk today.

Back to Top 


StitchR.W. (Bill) Stich, MS, PhD
Professor of Parasitology, Department Veterinary Pathobiology
University of Missouri
Columbia, MO

Persistence of Tick-Borne Infections

Dr. Bill Stich is a Professor of Parasitology in the University of Missouri Department of Veterinary Pathobiology. Bill has worked with a diverse range of metazoan, protozoan and rickettsial parasites that include ticks (Dermacentor, Rhipicephalus, Amblyomma and Ixodes spp.), Schistosoma mansoni, Babesia bovis, Sarcocystis neurona, Neospora caninum, Anaplasma marginale, A. phagocytophilum, Ehrlichia canis and E. chaffeensis. Most of Bill’s work currently involves tick-borne parasites and pathogens, for which he utilizes molecular, proteomic, cellular, immunological and clinical technologies to investigate interactions between these pathogens and their invertebrate and vertebrate hosts.

Bill earned his academic degrees in Veterinary Parasitology at Oklahoma State University, where he studied Anaplasma marginale, a rickettsial pathogen of cattle. These graduate studies included a year of training in the Molecular Biology Division of the Onderstepoort Veterinary Research Institute in South Africa. Bill then studied Schistosoma mansoni, a human ‘blood fluke’, as a postdoctoral research fellow under the auspices of an NIH training grant titled “Molecular and Cell Biology of Parasites and Vectors” at the University of Georgia. Bill then moved to Washington State University to work as a postdoctoral research associate on an NIH grant to investigate innate and adaptive cellular immunity of cattle to Babesia bovis, an important protozoan parasite that causes a highly pathogenic form of bovine babesiosis that is similar to severe human malaria.

After a short time at WSU, Bill joined the faculty of Veterinary Preventive Medicine at The Ohio State University as an assistant professor, where he continued to work on parasitic diseases of livestock caused by intracellular protozoan parasites. It was during this time when Bill began to work with tick-borne pathogens that infect dogs and people. After promotion with tenure at Ohio State, Dr. Stich then transferred to the Department of Veterinary Pathobiology at the University of Missouri as a tenured associate professor, to continue his work on tick-borne rickettsial pathogens in ‘lone star tick country.’ Bill also teaches the nematode and trematode sections of veterinary parasitology while he continues to pursue his long-standing interest in the mitigation of vector-borne diseases of medical and economic importance. These efforts include the control of tick-borne rickettsial diseases through better understanding of the mechanisms underlying transmission and pathogenesis of their etiologic agents. So far Bill has trained seven postdoctoral researchers, five of which were DVM/PhD’s, and he has served as major adviser for five MS and four PhD graduate students. Bill’s work has received support from several grants from the NIH and from industry. Bill also served as President for the Conference of Research Workers in Animal Diseases in 2009, he is a Councilor for the Society for Tropical Veterinary Medicine and on the Board of Directors for the Companion Animal Parasite Council. Bill currently serves on the editorial advisory board of the journal, Veterinary Parasitology, and he is editor in chief of Animal Health Research Reviews. 

Back to Top


stromdahlEllen Stromdahl, MS, BCE
US Army Public Health Command
Entomological Sciences Program
Aberdeen Proving Ground, MD

US Army Findings in Ticks in the Upper Midwest

Ellen Stromdahl is an entomologist and has worked in the Tick-Borne Disease Program of the U.S. Army Public Health Command (formerly U.S. Army Center for Health Promotion and Preventive Medicine) since 1995.


The Program operates the Tick-Borne Disease Laboratory and produces and disseminates educational materials on tick-borne disease prevention. The Laboratory identifies and tests ticks removed from DOD personnel submitted in the DOD Human Tick Test Kit Program.

Ms. Stromdahl’s research has focused on emerging human pathogens associated with the ticks found in the United States, including Ehrlichia sp. Wisconsin, or “EML”, and other pathogens associated with Ixodes scapularis in the Upper Midwest.

Back to Top


ViscontiErnest Visconti, MD
Attending in Medicine & Pediatrics
Lutheran Medical Center in Brooklyn;

Pediatric ID at Staten Island University Hospital &
Richmond University Medical Center
Private practice office location
Staten Island, New York

Helpful Hints in the Differential Diagnosis of Lyme Disease

Dr. Ernest Visconti has been attending in medicine and pediatrics at Lutheran Medical Center for 30 years. He also does pediatric ID at Staten Island University Hospital & Richmond University Medical Center. His private practice in infectious disease consists of treating patients with the following diseases: Lyme disease, chronic fatigue, fibromyalgia, Epstein-Barr, other tick-borne diseases, and many other disabilities.

Dr Visconti is also a pediatrician and has a large practice on Staten Island. There he sees well children for their examinations and vaccines. He also sees children with disabilities.

Back to Top

 


 

ZakrisonLeila Zackrison, MD, FACR, FACP
Internal Medicine, Rheumatology
Private Practice Fairfax, VA

Lyme Disease: Rheumatologic/Autoimmune Differential

Leila H Zackrison, MD, FACR, FACP, FAARM, a board certified physician earned her Bachelor of Science, Master of Science and a Doctorate of Medicine from Loma Linda University in California. She did her internship and residency in Internal Medicine and Rheumatology fellowship at Georgetown University Medical Center Washington DC. Dr. Zackrison, (Dr. Z. as she is affectionately called by her patients) is licensed in the Commonwealth of Virginia to practice Medicine and Surgery. She is a Fellow of the American College of Physicians and American College of Rheumatology, and a Fellow of American Academy of Anti-Aging, Regenerative and Functional Medicine. She has been in private practice since 1993 treating patients nationwide using an integrative medicine approach.

Back to Top

 

 




LDA Annual Conf. (June 2013) – Registration

LDA’s 14th Annual Conference

Lyme & Tick-Borne Diseases: Science, Research & Myth

Saturday, June 1 & Sunday June 2, 2013 

University of Minnesota, St. Paul

11.0 Prescribed CME Credits *

 

StPaulStudCtr

 Sponsored by  

  Lyme Disease Association, Inc. 

Co-Chairs

Brian Fallon, MD, Columbia Univ. College of Physicians & Surgeons

RW Stich, PhD, University of Missouri

   


This conference is designed for physicians and researchers.  Other health care professionals and the public are also invited to register.  Adults only.

Online General Registration – [For those who do not require Continuing Medical Education (CME) credits] 

Online CME* Registration  

Printable By Mail Registration Form

Questions on registration contact: treasurer@lymediseaseassociation.org


General Registration Information

►  Fees:
• Regular – $195 (after 5/8/13); $215 (at door – CASH or CHECK only)
• CME – $320 (after 5/8/13); $355 (at door – CASH or CHECK only)

Note: Early registration discount expires on 5/8/13

►  No phone or fax registrations accepted 

►  The availability of last minute “at the door” registrations is determined by the room capacity and number of registrants on day of conference.  Please note, the rate to register “at the door” will be higher than the pre-registration fee.  There is a CASH or CHECK ONLY policy when registering “at the door”. 

►  CANCELLATION: Written notice of cancellation must be received by LDA by 5/8/13 for refund, NO exceptions.  Email cancellation notice to treasurer@LymeDiseaseAssociation.org or fax 732-938-7215

►  AVAILABILITY: Registration subject to space availability at the time of receipt by LDA of completed registration. NO registrations accepted without payment.  


Note : “The University of Minnesota is not endorsing or sponsoring the activities conducted by Lyme Disease Association, Inc. on the University of Minnesota campus. The relationship between the University of Minnesota is solely that of licensor and licensee.”  *Application for CME credit has been filed with the American Academy of Family Physicians

 


 

* This Live activity, Lyme & Other Tick-Borne Diseases: Science, Research & Myth, with a beginning date of 06/01/2013, has been reviewed and is acceptable for up to 11.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/AAFP Equivalency:
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

 

 




2013 LDA Conference Agenda

11.0 Prescribed CME Credits for Physicians

Saturday Agenda     Sunday Agenda    Conference Information

Lyme & Other Tick-Borne Diseases:  Science, Research & Myth

AGENDA – SATURDAY JUNE 1, 2013

7:15 – 8:00 AM

REGISTRATION/EXHIBITS/CONTINENTAL BREAKFAST

8:00 – 8:10 AM

Patricia V. Smith, President, Lyme Disease Association, Inc.
Welcome & Remarks

8:10 – 8:20 AM

Patricia V. Smith, President, Lyme Disease Association, Inc.
Brief Lyme Overview & Intro of Facilitator: Dr. RW (Bill) Stich

8:20 – 9:00 AM

George Chaconas, PhD    Saturday Keynote Speaker
Live Imaging Studies of Dissemination of the Lyme Spirochete in Mice

Myths

 

9:00 – 9:30 AM

Kenneth Liegner MD
Problems of Lyme Disease Testing

9:30 – 10:00 AM

John Aucott MD
Erythema Migrans (EM) in Lyme Diagnosis

10:00-10:30 AM

Brian A. Fallon, MD, MPH
Lyme Disease or Hypochondriasis

10:30-10:40 AM

MORNING COFFEE BREAK

10:40-11:00 AM

Discussion (Myth panel)

Ticks & TBD’s

 

11:00-11:35 AM

Ellen Stromdahl, MS
US Army Findings in Ticks from the Upper Midwest

11:35-12:10 PM

RW Stich, PhD
Persistence of Tick-Borne Infections

12:10–12:45 PM

Edward Breitschwerdt, DVM
Bartonelliosis: A One Health Approach to a Persisitent Blood-Borne Infection

12:45-1:45 PM

LUNCH BREAK

1:45 PM

Introduction of Session Facilitator:
Elizabeth Maloney, MD

1:45 – 2:00 PM

Discussion (Ticks & Tick-Borne Diseases panel)

Differential Diagnosis

2:00 – 2:35 PM

Richard Rhee, MD
Lyme Disease: Neurologic Differential

2:35 – 3:10 PM

Ernest Visconti, MD
Helpful Hints in the Differential Diagnosis of Lyme Disease

3:10 – 3:25 PM

AFTERNOON COFFEE BREAK

3:25 – 4:00 PM

Leila Zackrison, MD
Lyme Disease: Rheumatologic/Autoimmune Differential

4:00 − 4:35 PM

Sam T. Donta, MD
Issues in the Treatment of Lyme Disease

4:35 − 5:00 PM

Discussion (Afternoon panel)

5:15 – 6:45 PM

NETWORKING RECEPTION

 

 

 

 

 

 

AGENDA – SUNDAY JUNE 2, 2013

7:30 – 8:00 AM

REGISTRATION/EXHIBITS/CONTINENTAL BREAKFAST

8:00 AM

Patricia V. Smith Introduces Session Facilitator:
Brian A. Fallon, MD

8:00 – 8:35 AM

Madeleine Cunningham, PhD
Anti-Neuronal Antibiodies in Lyme Disease

8:35–9:15 AM

Judith Miklossy, MD, PhD, DSc  Sunday Keynote Speaker   Neuropathophysiology of Late/Chronic Lyme Disease & its Relation with Alzheimer’s Disease

9:15–9:50 AM

Nicole Baumgarth, DVM, PhD
B Cell Subversion During Borrelia Infection – A Persistence Strategy?

9:50–10:00 AM

MORNING COFFEE BREAK

10:00–10:35 AM

A.T. Charlie Johnson, PhD
Detecting Lyme Disease Using Antibody-Functionalized Single-Walled Carbon Nanotube Transistors 

10:35–11:10 AM

Sam Shor, MD, FACP
Chronic Fatigue Syndrome & Lyme Disease – Is There A Connection?

11:10-11:45 PM

 

11:45-12:00 N

Elizabeth Maloney, MD
The Ethics of Clinical Decision-Making When the Scientific Evidence is Unclear or Absent

DISCUSSION PANEL

 

 




LDA Lyme Conference: Completed

The Lyme Disease Association,Inc. announces its 14th annual scientific conference, Lyme & Other Tick-Borne Diseases: Science, Research & Myth. The Conference will be held at the University of Minnesota, St. Paul, MN, on Saturday June 1 and Sunday June 2, 2013. 11.0 Prescribed CME Credits are available for Physicians.* Cash or check registration only at the door. 

Occi Tick QuestingV277kb

Brian A. Fallon, MD, Columbia University College of Physicians & Surgeons and RW (Bill) Stich, PhD, University of Missouri, are conference co-chairs.  Betty Maloney, MD, of Minnesota, also serves on the Planning Committee with the co-chairs.

The conference is designed for physicians and scientists, but the public is invited to register to attend. See the agenda for faculty and topics. Continue to check this website for future registration, additional information about the conference, and exhibitor opportunities. 

University of Minnesota
Continuing Education and Conference Center
1890 Buford Avenue
St. Paul, MN 55108

Click here for directions & Parking Info

Click here for Agenda

Click here for Faculty Biographies
Click here for Conference Flyer


“The University of Minnesota is not endorsing or sponsoring the activities conducted by Lyme Disease Association, Inc. on the University of Minnesota campus. The relationship between the University of Minnesota is solely that of licensor and licensee.” 


* This Live activity, Lyme & Other Tick-Borne Diseases: Science, Research & Myth, with a beginning date of 06/01/2013, has been reviewed and is acceptable for up to 11.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/AAFP Equivalency:
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

 



2012 Annual Scientific Conference: Microbial Persistence & Tick-Borne Diseases New Scientific & Clinical Directions

Co-sponsored by Columbia University & Lyme Disease Association, Inc. 

13th Annual Scientific Conference

Held on Saturday, September 29 & Sunday September 30, 2012

Hyatt Bellevue, Philadelphia, PA

View Brochure:  List of Speakers, Agenda, Program Accreditation and Miscellaneous
View Conference Summary: by Jessica Thomson
 
Faculty Bios
Click picture for Faculty biographies
 
 
 
 
 
 
2012 Conf Speak LQ14
Click picture for conference photo album 
 
 
 
 
 
 

 

 

 

 




Columbia Lyme & TBD Research Center

The Lyme and Tick-Borne Diseases Research Center at Columbia University Medical Center, established in 2007 by the Lyme Disease Association, Inc. and the Lyme Disease Alliance, Inc. (previously Time for Lyme, Inc), continues its focus on conducting research to identify better diagnostics and treatments for patients with chronic symptoms related to Lyme and other tick-borne diseases.

The research and clinical team includes neurologists, psychiatrists, rheumatologists, immunologists, brain imaging analysts, neuropsychologists, and biostatisticians. Current on-going or planned research is focused on further delineating the complex relationship between the immunologic response and the central nervous system in patients with chronic symptoms, testing novel treatment strategies (immune modulatory, brain stimulation, antibiotic), examining the long-term outcome of patients after treatment, identifying biomarkers that may aid in treatment selection, exploring post-mortem specimens from generous donors with well-documented Lyme disease, and collaborating on the development of new diagnostic assays.

In addition, the Center houses a specimen repository from patients with well-characterized Lyme disease and the Center staff educates medical students, residents, and post-residency fellows on the diagnosis and treatment of tick-borne diseases. The Center’s mission is facilitated by the members of its Scientific Advisory Board composed of scientists and clinicians from prominent academic institutions. The Center’s activities are supported by its Advisory Committee and by gifts from donors, private foundations, and state and federal sources. To learn more, go to www.columbia-lyme.org.

2012-ColumbiaTeamSm

 

 

 

 

Columbia Team Members:
Avi Chandra, Charu Sood, Sonya Martin, Roger Hicks,Brian Fallon